| Challenge title | R&D of new drugs and medical equipment |
| Form of partnership | Chinese company looking for technology partners |
| Category |
Tech & Electronics; Life Science & Healthcare |
| Challenge description | Challenge background:
The company was founded in 1946, is one of the earliest penicillin manufacturers in China. The company is a diversified and modern high-tech pharmaceutical enterprise integrating drug R&D, production and sales.. The company takes drug development as the core, adheres to the innovation orientation, forms a R&D system of innovative drugs and generic drugs around the fields of anti-infection, anti-coagulant, digestive system and intensive care through independent R&D, cooperative development and licensing, and establishes a product pipeline of the whole industrial chain of chemical and biological drugs. The company actively explores cutting-edge technical fields such as phage therapy and gene therapy, and continuously improves its innovation ability. Over the years, the company has repeatedly won the National Science Conference Award for significant contributions, National Science progress award, China chemical pharmaceutical enterprises in the top 100 brands and anti-infective brand ten and so on. And the company got the title of “well-known trademark” in 2011. Carry forward our cause and forge ahead into the future, The company has grown into a large pharmaceutical enterprise with more than 1000 employees and an area of more than 200,000 square meters, after more than 70 years of struggle. At present, the company has developed 9 APIs, and successfully applied for more than 150 preparation production approval documents. The company has built two production bases, which can produce 800 billion units of macromolecular heparin, 5,000 kg of low-molecular heparin, more than 400 tons of APIs, 400 million doses of powder and 100 million capsules every year. In the future, The company will further devote itself to product innovation, technology innovation, system innovation and management innovation, and open up a broader road of enterprise development. We are willing to work with colleagues from all walks of life to make contributions to the health cause of human beings and the development of Chinese Pharmaceutical. We are looking for companies with knowledge of the following requirements:
License-in or sales of listed foreign and domestic products.
License-in or sales of listed foreign and domestic products.
License-in or sales of listed foreign and domestic products. |
| Publication date | 2022-08-03 |
| Source | NETC |
